| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.009 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |